Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.21.2
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Product sales, net $ 5,107 $ 5,564 $ 15,079 $ 19,230
Cost of goods sold 2,749 3,106 8,073 10,442
Gross Profit 2,358 2,458 7,006 8,788
Operating expenses:        
Research and development 410 412 821 2,667
Selling, general and administrative 4,928 5,197 15,788 19,249
Total operating expenses 5,338 5,609 16,609 21,916
Operating Loss (2,980) (3,151) (9,603) (13,128)
Other Expenses [Abstract]        
Gain on debt extinguishment (2,945) 0 (2,945) 0
Interest expense, net 5 6 28 0
Loss before income taxes (40) (3,157) (6,686) (13,128)
Income tax expense (benefit) 0 0 11 (138)
Net Loss $ (40) $ (3,157) $ (6,697) $ (12,990)
Weighted average common shares outstanding, basic (shares) 109,115 99,950 107,099 99,831
Weighted average common shares outstanding for diluted (shares) 109,115 99,950 107,099 99,831
Net loss per common share, basic (in USD per share) $ (0.00) $ (0.03) $ (0.06) $ (0.13)
Net loss per common share, diluted (in USD per share) $ (0.00) $ (0.03) $ (0.06) $ (0.13)
Revenue, product and service [Extensible List]     Product [Member]